Built from the field up — not the corner office down

Eight years. Two divisions built from nothing. 700+ procedures.

Mike Roark is a MedTech commercial leader who has spent the last eight years building physician networks, activating IDE trial sites, and scaling commercial divisions from zero. His methodology for physician engagement, KOL activation, and commercial infrastructure works across all MedTech specialties and physician categories.

His defining professional characteristic is getting to the right physician quickly. He has built KOL networks, activated physicians for IDE-stage clinical trials, and driven procedural adoption at programs across Ohio, Kentucky, and Indiana — not by directing others, but as the hands-on operator who built the relationships and the programs himself.

At Inari Medical, he launched and scaled the Ohio/Kentucky VTE territory from $200K to over $6M annually — hitting 156% of quota in his first year and 230% in his third. He supported 700+ VTE procedures across the region and built a KOL education program that drove physician adoption and hospital VTE program development across a multi-state footprint. Inari was later acquired by Stryker for $4.9 billion in February 2025.

At Argon Medical, he was recruited as the first dedicated commercial leader for a newly formed Vascular division — given $6.37M in existing revenue, no sales team, no territory design, and no commercial playbook. In under two years, he more than doubled division revenue, scaled the national team from 10 to 30 representatives, and designed every element of the commercial infrastructure from scratch.

He holds an MBA in Healthcare Commercialization and AI Integration from Northern Kentucky University, completed Summa Cum Laude. His capstone analysis — "Building Category-Defining Companies: Commercial Principles from the MedTech Industry's Most Successful Ventures" — examined the commercial architecture that made Inari Medical one of the most successful MedTech startups of the last decade.